Curriculum
Vitae
Christopher Southan
B.Sc.Hons, M.Sc., Ph.D., Special Prof.

Summary:
- Experienced and accomplished multidisciplinary senior
bioscientist
- Record of high achievement in bioinformatics,
proteomics, genomics, bioactive chemical databases, drug target discovery
and protein chemistry.
- Extensive background in pharmaceutical and
biotechnology R&D.
- Successes in team leadership, project management and
strategy planning
- Over 70 publications including 40 peer-reviewed
papers
- Over 20 published patents, 10 of which have been
granted.
- Many invited external presentations
- Wide network of academic and commercial contacts
Details: http://www.cdsouthan.info/CDS_prof.htm or http://www.linkedin.com/in/cdsouthan
Contact: Swedish mobile +46(0)702-530710, home +46 (0)31681630 cdsouthan@hotmail.com
***********************************************************************
Recent Employment Achievements:
May 2008 – July 2009 ELIXIR
Database Survey Co-ordinator, EMBL Outstation, European Bioinformatics
Institute, Wellcome Trust Genome Campus, Hinxton, UK
- Developed a comprehensive
questionnaire to capture key metrics from European database providers for
the ELIXIR project (http://www.elixir-europe.org/)
- Completed pilot survey and distributed
main survey to over 480 databases
- Results included in
ELIXIR-related presentations by the EBI Director, Deputy Director and
other Work Package leaders
- Exploration of display methods
for result analysis
- Committee member for Work
Package 2 (ELIXIR Strategy for Data Resources)
- Inputs to EBI Druggablity
Portal and Biomolecular Interaction Standards
Jan 2006 – Nov 2007: Internal Secondment to Global Compound Science, DECS Lead
Generation, Computational Chemistry, Mölndal
- Supported
development of a major database application of targets, compounds and assay data by
presentations, user documentation and exploitation examples
- Provided strategic
impact assessment, awareness presentations and exploitation guidelines for
PubChem and other external sources of bioactive compound data
- Successful
bioinformatics support for specific computational chemistry projects
- Key deliveries of
gene>pharmacology mappings for internal databases
- Developed global
contact network for drug target sequence-to-compound relationships,
including managers at GVKBIO, PubChem, and DrugBank
March 2004 – Dec 2005:
Principal Scientist, Target Development & Bioinformatics,
Department of Molecular Pharmacology AstraZeneca R&, Mölndal, Sweden.
- Managed a team of five bioinformaticians and
two Masters Students that produced major Departmental and global project
impacts
- Provided advanced bioinformatic analysis for
the decision support and progression of 16 projects including the Protease
Platform
- Awarded two promotions and Swedish expert tax
reduction status in 2004
- Key inputs to the AZ global Bioinformatics
Strategy Steering Group and Target Development & Bioinformatics
Section Management Team
- Lead Working Group that successfully introduced
global unrestricted utilisation of external bioinformatics resources
- Contributed to business case for successful
major investment in bioinformatics workflow capability
- Appointed Special Professor in Proteomics at University of Nottingham
Dec 2001 – Jan 2004:
Proteome Discovery
Bioinformatician, Oxford GlycoSciences
.
- Discovery
of unknown proteins, splice variants, SNPs and other marketing examples
from the Protein Atlas of the human genome database.
- Presentations
to Confirmant Scientific Advisory Board on human gene number resulted in
major revenue gain for OGS and a paper in Proteomics
- Inputs
for database rationalisation, cross-species comparisons, ontologies, and
analysis of unknown proteins provided for major OGS customer projects.
- Delivered
11 external presentations, published four papers and three chapters
- Two
Bioinformatics M.Sc. students awarded distinctions.
Jan 2001-Dec 2001: Head of Computational Biology,
Gemini Genomics, Cambridge
- Key
results generated from analysis of candidate disease-associated genes.
- Supervised
selection of key gene target classes for coding SNP mining.
- Managed
a major external project to identify all non-synonymous SNPs providing a
key resource for disease-association studies.
- Valued
inputs to Business Development for progressing collaborations.
Oct 1987-Dec 2000: Senior Investigator, Bioinformatics Target Discovery, SmithKline
Beecham, Harlow. Initially working as a Protein
Chemist and HPLC specialist (1987-1995) then internally recruited into
Bioinformatics Target Discovery (1996-2000).
- Analysis
of proteomic data discovered novel family of rat secreted Ly6 proteins.
- Six
publications appearing in 2000
- Project
leader for mining novel proteases from EST and genomic data. This
discovered 170 novel protease and inhibitor sequences, was extended for
two years because of the success rate,
produced over 20 patents and spawned several drug target studies
including the Alzheimer’s beta-secretase, BACE1
- Managed
a team that used robotics and cocktail mixtures to achieve a screening
record of 1130 compounds for HPLC peptidolytic viral protease assays.
- Invented
plastic high-speed microbore HPLC columns used in many projects for
protein purification
- Complete
sequence of 2nd novel lipase (NSDL) assembled from EST data confirmed as
98 % correct. Patents filed and drug target study initiated.
- Breakthrough
identification of novel LpPLA2 enzyme sequence in Human Genome
Sciences EST data. This was highlighted as a major success in being the
first SB genomic target approved for development
- Introduction of MALDI peptide mass-mapping for
proteins from 2D gels.
- Operation
of ABI 477 protein sequencer for extensive sequencing of Dopamine beta
hydroxylase and elucidation of attachment sites of mechanistic inhibitors
- Successful
co-supervision of four Ph.D. students and two Sandwich
students
***********************************************************************
University Qualifications:
Nationality: British, Sex: male, Marital status:
married with three children, Date of
birth: 19/05/52.